---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-094447"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2026-08-27T21:29:32+00:00"
generated_at: "2026-08-27T21:32:24.519801+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical appoints Robert Potashnick as Chief Accounting Officer and VP of Finance

## Summary
- Base salary $315,000/yr; initial target bonus of 15% of salary tied to performance milestones.
- Initial equity award of 250,000 stock options at $0.746/share (Aug 24, 2026 closing price).
- Employment agreement provides 6 months severance for qualifying terminations; 3-year term with auto-renewal.
- Potashnick previously served as Interim CFO on contractor basis; prior CFO at FOXO Technologies and Flutterbee Education Group.

## SEC filing metadata
- accession: 0001213900-26-094447
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2026-08-27T21:29:32+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390026094447/0001213900-26-094447-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390026094447/ea0303543-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-094447
- JSON: https://secwatch.observer/filing/0001213900-26-094447.json
- Plain text: https://secwatch.observer/filing/0001213900-26-094447.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.